Since MLH1 promoter methylation and germline mutation in MLH1 and MSH2 are the most frequent causes of MMR deficiency in gastric cancer, some institutes use only MLH1 and MSH2 in the diagnostic routine [43]. This evidence concerns the gene MSH2 and gastric cancer.